Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC) is an innovative, fast-growing healthcare company that discovers and develops new compounds that address unanswered medical needs and advance human health. With a strong focus on neuroscience, oncology, and cardio-renal treatments, OPDC is dedicated to improving the health and quality of human life. For more information, visit www.otsuka-us.com.
OPDC is a subsidiary of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd. The Otsuka Group employs approximately 42,000 people globally and its products are available in more than 80 countries worldwide. Otsuka welcomes you to visit its global website at https://www.otsuka.co.jp/en/.
The Manager, Technical Services will be responsible for various activities under the direction of the Director of Sterile Dosage Technologies. These include performing process development/scale-up studies, participating in the manufacture of cGMP clinical lots, and transfer of processes to clinical or commercial manufacturing facilities for new drug candidates or existing commercial products. Experience with biologic and combination products regulations and development (including Human Factor Studies) is a plus.